Five Point Holdings, LLC (“Five Point” or the “Company”) (NYSE:FPH) today announced that Five Point Operating Company, LP, through which Five Point owns all of its assets and conducts all of its operations (the “Issuer”), and Five Point Capital Corp., a wholly owned subsidiary of the Issuer (together with the Issuer, the “Issuers”), commenced an offer to Eligible Holders (as defined herein) to exchange (such offer, the “Exchange Offer”) any and all of the Issuers’ outstanding 7.875% Senior Notes due 2025 (CUSIP: 33834Y AA6 / U33825 AA5; ISIN: US33834YAA64 / USU33825AA54) (the “Existing Notes”) for 10.500% Initial Rate Senior Notes due 2028 (the “New Notes”), pursuant to the terms and subject to the conditions set forth in the exchange offer memorandum and consent solicitation statement, dated December 11, 2023, in respect of the Exchange Offer and Solicitation of Consents (each, as defined below) (the “Exchange Offer Memorandum”).
What’s Going On With Biodexa Pharmaceuticals Stock (BDRX) Today?
Biodexa Pharmaceuticals PLC-ADR (NASDAQ: BDRX) shares are trading lower by 6.8% to $4.76 Tuesday morning after the company announced an offering of 1,397,849 Class A Units at an assumed public offering price of $2.79 per Class A Unit in a preliminary prospectus.
